• Explore /
  • Poster
  • / Long-term follow-up results of a phase II study of dose-adjusted (DA)-EPOCH-R with high-dose methotrexate (HD-MTX) for newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma (CD5+ DLBCL).

Long-term follow-up results of a phase II study of dose-adjusted (DA)-EPOCH-R with high-dose methotrexate (HD-MTX) for newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma (CD5+ DLBCL).

Abstract Poster

Authors

null

Kana Miyazaki

Mie University Graduate School of Medicine, Tsu, Japan

Kana Miyazaki , Rika Sakai , Noriko Iwaki , Go Yamamoto , Tomomi Yamada , Yuki Nishimura , Satoshi Tamaru , Naoko Asano , Kohta Miyawaki , Koji Izutsu , Tomohiro Kinoshita , Ritsuro Suzuki , Koichi Ohshima , Koji Kato , Naoyuki Katayama , Motoko Yamaguchi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Track

Hematologic Malignancies

Sub Track

Non-Hodgkin Lymphoma

Clinical Trial Registration Number

UMIN000008507

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 7551)

DOI

10.1200/JCO.2021.39.15_suppl.7551

Abstract #

7551

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Kana Miyazaki

First Author: Alessia Castellino

First Author: Dai Chihara

First Author: Nicholas James Short